Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.
The Journal of Infectious Diseases|December 16, 2003
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative womenRaphael P Viscidi, Linda Ahdieh-Grant, Michael F Schneider, et al.
European Journal of Immunology|April 14, 2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severityFederica Frasca, Mirko Scordio, Letizia Santinelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2011
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individualsRaphael P Viscidi, Nina Khanna, Chen S Tan, et al.
International Journal of Cancer|February 14, 2003
Lack of serological evidence for an association between simian virus 40 and lymphomaSilvia de Sanjose, Keerti V Shah, Eva Domingo-Domenech, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Raphael P Viscidi, Cathee Till, et al.
Medical Microbiology and Immunology|November 11, 2024
MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effectLicia Bordi, Alessandra D'Auria, Federica Frasca, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective studySiobhan Sutcliffe, Edward Giovannucci, Charlotte A Gaydos, et al.
International Journal of Cancer|June 30, 2005
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphomaEric A Engels, Dana E Rollison, Patricia Hartge, et al.
The Journal of Infectious Diseases|March 3, 2016
Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM StudyChristine M Pierce Campbell, Raphael P Viscidi, B Nelson Torres, et al.
Pageof 10